JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265981

Human WDR45 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

WDR45 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 3 and 1 bp insertion in exon 3.

View Alternative Names

JM5, NBIA4, WD repeat containing protein 45, WD repeat domain 45, WD repeat domain phosphoinositide interacting protein 4, WD repeat domain, X linked 1, WD45 repeat protein interacting with phosphoinositides 4, WDRX1, WDRXI4

2 Images
Sanger Sequencing - Human WDR45 knockout HeLa cell line (AB265981)
  • Sanger seq

Unknown

Sanger Sequencing - Human WDR45 knockout HeLa cell line (AB265981)

Allele-1 : 11 bp deletion in exon 3.

Sanger Sequencing - Human WDR45 knockout HeLa cell line (AB265981)
  • Sanger seq

Unknown

Sanger Sequencing - Human WDR45 knockout HeLa cell line (AB265981)

Allele-2 : 1 bp insertion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 3 and 1 bp insertion in exon 3

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265981-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265981 Human WDR45 knockout HeLa cell line", "number":"AB265981-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265981-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265981 Human WDR45 knockout HeLa cell line", "number":"AB265981-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
WDR45
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The WDR45 protein also known as WD repeat domain phosphoinositide-interacting protein 4 (WIPI4) plays a necessary role in the autophagic process. It is a protein of approximately 42 kDa and consists of seven WD40 repeats which facilitate protein-protein interactions. The protein is broadly expressed in various tissues particularly in the brain. These interactions are critical in autophagy a process for degrading and recycling cellular components.
Biological function summary

WDR45 contributes significantly to the regulation of autophagy. It acts as part of a multi-protein complex referred to as the autophagy-related 2 (ATG) complex. This complex is involved in autophagosome formation which is an important component in cellular degradation pathways. WDR45 binds phosphoinositides which are phospholipids integral to vesicle trafficking and membrane dynamics during autophagy.

Pathways

The influence of WDR45 is evident in the PI3K/Akt signaling and AMPK signaling pathways. These pathways regulate cellular energy homeostasis and the response to metabolic stress. PI3K/Akt and AMPK modulate the activity of the mTOR pathway which is known to suppress autophagy. WDR45 interacts with other autophagy-related proteins such as LC3 and ULK1 facilitating the initiation of the autophagic process.

The connection to WDR45 is pronounced in neurodegenerative diseases like beta-propeller protein-associated neurodegeneration (BPAN) and Parkinson's disease. Mutations in WDR45 lead to defective autophagy resulting in the accumulation of damaged organelles and proteins in neurons. It is linked to proteins involved in these disorders such as PINK1 and Parkin further highlighting its potential role in disease pathology through impaired mitochondrial quality control and neural damage.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com